TRANSPLANTATION PROCEEDINGS, cilt.43, sa.3, ss.805-808, 2011 (SCI-Expanded)
Aim. Anti-donor antibodies, denoted as "panel-reactive antibodies" (PRAs), are one of the most important factors influencing graft survival after renal transplantation. PRA is generally analyzed with enzyme-linked immunosorbent assay or flow cytometry (FC), which identify the HLA antigen specific for the preformed antibody.